Acorda Therapeutics Announces Positive Results of Phase 3 Study of
Fampridine-SR on Walking in People with Multiple Sclerosis
-Statistical significance achieved on all three efficacy ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Wednesday, September 27
by
All About MS
on Wed 27 Sep 2006 10:21 AM CST
|
||